Skip to main content
. 2017 Nov;23(11):10.18553/jmcp.2017.23.11.1169. doi: 10.18553/jmcp.2017.23.11.1169

TABLE 3.

Adjusted Mean All-Cause Costs by Key Cost Drivers

Number of Claims Adjusted Mean All-Cause Health Care Costsa (95% CI), $
Opioid claims
0 8,888 (8,862-8,914)
1-2 10,873 (10,827-10,919)
3-6 12,995 (12,910-13,079)
7+ 15,210 (15,113-15,307)
Triptan claims
0 10,753 (10,717-10,790)
1-3 9,422 (9,389-9,455)
4-6 10,300 (10,230-10,371)
7+ 11,517 (11,438-11,596)
Medication use
Prophylactic medication only 9,845 (9,740-9,951)
Acute medication only 9,978 (9,740-9,951)
Prophylactic and acute medication 10,983 (10,935-11,031)
Neither prophylactic nor acute medication 10,354 (10,289-10,419)
Migraine-related ER visits
≥ 2 visits 13,358 (13,082-13,639)
< 2 visits 10,233 (10,213-10,253)
Neurologist visits
Yes 11,794 (11,743-11,845)
No 9,868 (9,846-9,890)

aAdjusted for age, gender, plan type, region, DCI, baseline comorbidities and medications of interests, and other clinical characteristics.

CI = confidence interval; DCI = Deyo-Charlson Comorbidity Index; ER = emergency room.